{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:17:17Z","timestamp":1777652237234,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The degree of contamination of healthy tissue with tumor cells during a biopsy in bone or soft tissue sarcomas is clearly dependant on the type of biopsy. Some studies have confirmed a clinically relevant contamination of the biopsy tract after incisional biopsies, as opposed to core-needle biopsies. The aim of our prospective study was to evaluate the risk of local recurrence depending on the biopsy type in extremity and pelvis sarcomas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 162 patients with a minimum follow-up of 6 months after wide resection of extremity sarcomas. All diagnostic and therapeutic procedures were performed at a single, dedicated sarcoma center. The excision of the biopsy tract after an incisional biopsy was performed as a standard with all tumor resections. All patients received their follow-up after the conclusion of therapy at our center by means of regional MRI studies and, at a minimum, CT of the thorax to rule out pulmonary metastatic disease. The aim of the study was the evaluation of the influence of the biopsy type and of several other clinical factors on the rate of local recurrence and on the time of local recurrence-free survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred sixty-two patients with bone or soft tissue tumors of the extremities and the pelvis underwent either an incisional or a core-needle biopsy of their tumor, with 70 sarcomas (43.2%) being located in the bone. 84.6% of all biopsies were performed as core-needle biopsies. The median follow-up time was 55.6 months, and 22 patients (13.6%) developed a local recurrence after a median time of 22.4 months. There were no significant differences between incisional and core-needle biopsy regarding the risk of local recurrence in our subgroup analysis with differentiation by kind of tissue, grading of the sarcoma, and perioperative multimodal therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In a large and homogenous cohort of extremity and pelvic sarcomas, we did not find significant differences between the groups of incisional and core-needle biopsy regarding the risk of local recurrence. The excision of the biopsy tract after incisional biopsy in the context of the definitive tumor resection seems to be the decisive factor for this result.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-021-02481-2","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T07:02:46Z","timestamp":1641884566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sarcomas of the extremities and the pelvis: comparing local recurrence after incisional and after core-needle biopsy"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-9872","authenticated-orcid":false,"given":"Alexander","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Birkenmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Fromm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kn\u00f6sel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorit","family":"Di Gioia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Roland","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"11","key":"2481_CR1","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s11999-010-1337-1","volume":"468","author":"J Yang","year":"2010","unstructured":"Yang J, Frassica FJ, Fayad L, Clark DP, Weber KL. Analysis of nondiagnostic results after image-guided needle biopsies of musculoskeletal lesions. Clin Orthop Relat Res. 2010;468(11):3103\u201311.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"2481_CR2","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.2106\/JBJS.N.00661","volume":"97","author":"F Traina","year":"2015","unstructured":"Traina F, Errani C, Toscano A, Pungetti C, Fabbri D, Mazzotti A, et al. Current concepts in the biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 2015;97(1):e7.","journal-title":"J Bone Joint Surg Am"},{"key":"2481_CR3","doi-asserted-by":"crossref","unstructured":"Klein A, Fell T, Birkenmaier C, Fromm J, Jansson V, Kn\u00f6sel T, et al. Relative sensitivity of core-needle biopsy and incisional biopsy in the diagnosis of musculoskeletal sarcomas. Cancers. 2021;13(6):1393.","DOI":"10.3390\/cancers13061393"},{"issue":"3","key":"2481_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s11999-012-2569-z","volume":"471","author":"O Binitie","year":"2013","unstructured":"Binitie O, Tejiram S, Conway S, Cheong D, Temple HT, Letson GD. Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract. Clin Orthop Relat Res. 2013;471(3):891\u20138.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"2481_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00256-017-2579-8","volume":"46","author":"MA Siddiqi","year":"2017","unstructured":"Siddiqi MA, Kim HS, Jede F, Han I. Association of core needle biopsy tract resection with local recurrence in extremity soft tissue sarcoma. Skelet Radiol. 2017;46(4):507\u201312.","journal-title":"Skelet Radiol"},{"issue":"2","key":"2481_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11999-016-5090-y","volume":"475","author":"I Barrientos-Ruiz","year":"2017","unstructured":"Barrientos-Ruiz I, Ortiz-Cruz EJ, Serrano-Montilla J, Bernabeu-Taboada D, Pozo-Kreilinger JJ. Are biopsy tracts a concern for seeding and local recurrence in sarcomas? Clin Orthop Relat Res. 2017;475(2):511\u20138.","journal-title":"Clin Orthop Relat Res"},{"key":"2481_CR7","first-page":"80","volume":"30","author":"S Saghieh","year":"2010","unstructured":"Saghieh S, Masrouha KZ, Musallam KM, Mahfouz R, Abboud M, Khoury NJ, et al. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J. 2010;30:80\u20133.","journal-title":"Iowa Orthop J"},{"issue":"5","key":"2481_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1590\/S0102-36162012000500015","volume":"47","author":"MP Oliveira","year":"2012","unstructured":"Oliveira MP, Lima PM, de Mello RJ. Tumor contamination in the biopsy path of primary malignant bone tumors. Rev Bras Ortop. 2012;47(5):631\u20137.","journal-title":"Rev Bras Ortop"},{"issue":"4","key":"2481_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cncr.30370","volume":"123","author":"D Berger-Richardson","year":"2017","unstructured":"Berger-Richardson D, Swallow CJ. Needle tract seeding after percutaneous biopsy of sarcoma: risk\/benefit considerations. Cancer. 2017;123(4):560\u20137.","journal-title":"Cancer."},{"key":"2481_CR10","doi-asserted-by":"crossref","unstructured":"Bilgeri A, Klein A, Lindner LH, Nachbichler S, Kn\u00f6sel T, Birkenmaier C, et al. The effect of resection margin on local recurrence and survival in high grade soft tissue sarcoma of the extremities: how far is far enough? Cancers. 2020;12(9):E2560.","DOI":"10.3390\/cancers12092560"},{"issue":"1","key":"2481_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5301\/tj.5000696","volume":"104","author":"S Ferrari","year":"2018","unstructured":"Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, et al. EURO-B.O.S.S.: a European study on chemotherapy in bone-sarcoma patients aged over 40: outcome in primary high-grade osteosarcoma. Tumori. 2018;104(1):30\u20136.","journal-title":"Tumori."},{"key":"2481_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","volume":"109","author":"S Smeland","year":"2019","unstructured":"Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. (Oxford, England: 1990). 2019;109:36\u201350.","journal-title":"Eur J Cancer. (Oxford, England: 1990)"},{"issue":"27","key":"2481_CR13","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1200\/JCO.2008.16.5720","volume":"26","author":"M Paulussen","year":"2008","unstructured":"Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, et al. Results of the EICESS-92 Study: two randomized trials of Ewing\u2019s sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol. 2008;26(27):4385\u201393.","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"2481_CR14","doi-asserted-by":"publisher","first-page":"v198","DOI":"10.1093\/annonc\/mdq209","volume":"21","author":"PG Casali","year":"2010","unstructured":"Casali PG, Blay JY. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v198\u2013203.","journal-title":"Ann Oncol"},{"issue":"4","key":"2481_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jamaoncol.2017.4996","volume":"4","author":"RD Issels","year":"2018","unstructured":"Issels RD, Lindner LH, Verweij J, Wessalowski R, Reichardt P, Wust P, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. JAMA Oncol. 2018;4(4):483\u201392.","journal-title":"JAMA Oncol"},{"issue":"3","key":"2481_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3322\/caac.21605","volume":"70","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Gronchi A, Cardona K. Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J Clin. 2020;70(3):200\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 4","key":"2481_CR17","doi-asserted-by":"publisher","first-page":"iv79","DOI":"10.1093\/annonc\/mdy310","volume":"29","author":"PG Casali","year":"2018","unstructured":"Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv79\u201395.","journal-title":"Ann Oncol"},{"issue":"2","key":"2481_CR18","first-page":"106","volume":"22","author":"MP Oliveira","year":"2014","unstructured":"Oliveira MP, Lima PM, da Silva HJ, de Mello RJ. Neoplasm seeding in biopsy tract of the musculoskeletal system. A Syst Rev. 2014;22(2):106\u201310.","journal-title":"A Syst Rev"},{"issue":"2","key":"2481_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1200\/JCO.2017.75.2717","volume":"36","author":"JG Crompton","year":"2018","unstructured":"Crompton JG, Ogura K, Bernthal NM, Kawai A, Eilber FC. Local control of soft tissue and bone sarcomas. J Clin Oncol. 2018;36(2):111\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2481_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12885-018-4741-7","volume":"18","author":"J Fromm","year":"2018","unstructured":"Fromm J, Klein A, Baur-Melnyk A, Kn\u00f6sel T, Lindner L, Birkenmaier C, et al. Survival and prognostic factors in conventional central chondrosarcoma. BMC Cancer. 2018;18(1):849.","journal-title":"BMC Cancer."},{"issue":"10","key":"2481_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1302\/2058-5241.2.170005","volume":"2","author":"MA Smolle","year":"2017","unstructured":"Smolle MA, Andreou D, Tunn PU, Szkandera J, Liegl-Atzwanger B, Leithner A. Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk. EFORT Open Rev. 2017;2(10):421\u201331.","journal-title":"EFORT Open Rev"},{"issue":"4","key":"2481_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/CCO.0000000000000093","volume":"26","author":"S Sleijfer","year":"2014","unstructured":"Sleijfer S, Gelderblom H. Current clinical trials for advanced osteosarcoma and soft tissue sarcoma. Cur Opin Oncol. 2014;26(4):434\u20139.","journal-title":"Cur Opin Oncol"},{"key":"2481_CR23","doi-asserted-by":"crossref","unstructured":"Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H. Therapeutic targets for bone and soft-tissue sarcomas. Int J Mole Sci. 2019;20(1):170.","DOI":"10.3390\/ijms20010170"},{"issue":"5","key":"2481_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2106\/00004623-199605000-00004","volume":"78","author":"HJ Mankin","year":"1996","unstructured":"Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996;78(5):656\u201363.","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"2481_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00132-020-03875-y","volume":"49","author":"D Winkler","year":"2020","unstructured":"Winkler D, Fritzsche H, Schaser KD, Hofbauer C. Biopsy of musculoskeletal tumors: complications and avoidable errors. Der Orthopade. 2020;49(2):88\u201397.","journal-title":"Der Orthopade."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02481-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-021-02481-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02481-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T07:04:35Z","timestamp":1641884675000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02481-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2481"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02481-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written consent was obtained from all surviving patients included in this study. In accordance with the ethics committee, the data from non-surviving patients were irreversibly anonymized for statistical evaluation.The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Medical Faculty, University of Munich (ID 17-89).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}